A step towards equitable clinical trial recruitment: a protocol for the development and preliminary testing of an online prostate cancer health information and clinical trial matching tool

[1] Unger JM(2016)The role of clinical trial participation in cancer research: barriers, evidence, and strategies Am Soc Clin Oncol Educ Book 36 185-198

[2] Cook E(2011)A qualitative assessment of the experience of participating in a cancer-related clinical trial Support Care Cancer 19 49-55

[3] Tai E(2013)Patient perspectives on participation in the ENABLE II randomized controlled trial of a concurrent oncology palliative care intervention: benefits and burdens Palliat Med 27 375-383

[4] Bleyer A(1999)A prospective study of the serum prostate specific antigen concentrations and gleason histologic scores of black and white men with prostate carcinoma Cancer 86 836-841

[5] Wootten AC(2000)Ethnic and racial differences in prostate cancer incidence and mortality Ethn Dis 10 69-75

[6] Abbott JM(1995)Racial disparity in the association of p53 gene alterations with breast cancer survival Cancer Res 55 1485-1490

[7] Siddons HM(2003)Prognosis after rectal cancer in blacks and whites participating in adjuvant therapy randomized trials J Clin Oncol 21 413-420

[8] Rosenthal MA(2003)The importance of race and ethnic background in biomedical research and clinical practice N Engl J Med 348 1170-1175

[9] Costello AJ(2004)Participation in cancer clinical trials: race-, sex-, and age-based disparities JAMA 291 2720-2726

[10] Maloney C(2007)Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities Ann Surg Oncol 14 3328-3334

[1] Unger JM(2016)The role of clinical trial participation in cancer research: barriers, evidence, and strategies Am Soc Clin Oncol Educ Book 36 185-198

[2] Cook E(2011)A qualitative assessment of the experience of participating in a cancer-related clinical trial Support Care Cancer 19 49-55

[3] Tai E(2013)Patient perspectives on participation in the ENABLE II randomized controlled trial of a concurrent oncology palliative care intervention: benefits and burdens Palliat Med 27 375-383

[4] Bleyer A(1999)A prospective study of the serum prostate specific antigen concentrations and gleason histologic scores of black and white men with prostate carcinoma Cancer 86 836-841

[5] Wootten AC(2000)Ethnic and racial differences in prostate cancer incidence and mortality Ethn Dis 10 69-75

[6] Abbott JM(1995)Racial disparity in the association of p53 gene alterations with breast cancer survival Cancer Res 55 1485-1490

[7] Siddons HM(2003)Prognosis after rectal cancer in blacks and whites participating in adjuvant therapy randomized trials J Clin Oncol 21 413-420

[8] Rosenthal MA(2003)The importance of race and ethnic background in biomedical research and clinical practice N Engl J Med 348 1170-1175

[9] Costello AJ(2004)Participation in cancer clinical trials: race-, sex-, and age-based disparities JAMA 291 2720-2726

[10] Maloney C(2007)Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities Ann Surg Oncol 14 3328-3334